ViiV May Dodge Compulsory License For Celsentri In India; Commits To Competitive Price Via Local Ally
This article was originally published in The Pink Sheet Daily
Executive Summary
Unfazed by the recent compulsory license granted to Natco for Bayer’s Nexavar, ViiV closes in on a local partnership.